SCHEMBL32688289

SCHEMBL32688289

N#Cc1c(SCc2nnn[nH]2)[nH]c(=O)c(C#N)c1-c1ccc(-c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 1/20 0.40
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ TNF P01375 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ NOD2 Q9HC29 1/20 0.36
▸ NOD1 Q9Y239 1/20 0.36
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ HSD11B1 P28845 10/20 0.35
▸ HSD11B2 P80365 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688405 0.93 MEN1 (0.41) ADORA1KMT2AMEN1TNFPOLB
SCHEMBL32688147 0.90 HSD11B1 (0.40) ADORA1KMT2AMEN1TNFPOLB
SCHEMBL32688166 0.88 HSD11B1 (0.41) ADORA1KMT2AMEN1HSD11B1HSD11B2
SCHEMBL32688008 0.88 MEN1 (0.42) ADORA1KMT2AMEN1TNFPOLB
SCHEMBL32688269 0.88 HSD11B1 (0.45) KMT2AMEN1POLBHSD11B1ALDH1A1
SCHEMBL32688034 0.87 PDE9A (0.43) ADORA1KMT2AMEN1TNFPOLB
SCHEMBL32688160 0.87 HSD11B1 (0.36) ADORA1HSD11B1HSD11B2
SCHEMBL32688201 0.86 HSD11B1 (0.36) HSD11B1HSD11B2
SCHEMBL32687990 0.84 ADORA1 (0.44) ADORA1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL32688432 0.84 ADORA1 (0.40) ADORA1KMT2AMEN1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ADORA1 1595/4885KMT2A 3400/4885MEN1 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback